The Gain from Pain Mainly Explained: Fire Walk with Me[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. This article is third in a series on pain. You can see the first part here, and second part here. His words and opinions are his own, and he has agreed to our trading restrictions. Enjoy!] It’s the stuff of bucket lists: eating fugu […]
Articles
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
RE UniQure ($QURE) & $XENE Dr KSS, I seem to recall you mentioning $QURE on several occasions in a seemingly favorabl...
uniQure ($QURE) definitely raining on the $CLDN parade. CLDN's gene therapy works to mop up calcium during diastole s...
Dr. KSS any thoughts on UniQure (QURE). Came public at $17 a share and is using ddRNAi technology licensed from Benitec....